We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
134 hedge funds and large institutions have $241M invested in ANI Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% less call options, than puts
Call options by funds: $2.02M | Put options by funds: $2.08M
5% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 44
5% less funds holding
Funds holding: 141 → 134 (-7)
5.44% less ownership
Funds ownership: 66% → 60.56% (-5.4%)
26% less capital invested
Capital invested by funds: $325M → $241M (-$83.7M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
134
Holders Change
-7
Holders Change %
-4.96%
% of All Funds
2.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
42
Reduced
44
Closed
26
Calls
$2.02M
Puts
$2.08M
Net Calls
-$62K
Net Calls Change
-$2.24M
Top Buyers
| 1 |
TSW
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$10.6M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$8.28M |
| 3 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$5.12M |
| 4 |
Morgan Stanley
New York
|
+$4.1M |
| 5 |
BlackRock
New York
|
+$2.53M |
Top Sellers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$17.4M |
| 2 |
First Manhattan
New York
|
-$11M |
| 3 |
HRCM
Hawk Ridge Capital Management
Los Angeles,
California
|
-$8.01M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.79M |
| 5 |
Renaissance Technologies
New York
|
-$3.19M |